Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume X No. 12 - September 8, 2003

Changing the Way Laboratories Do Business

I HOPE BOTH PATHOLOGISTS AND LABORATORY ADMINISTRATORS pay close attention to our coverage of early-adopter hospital laboratories and how they are using “Lean” quality management methods to boost performance of their laboratories. These labs are harvesting productivity gains in the range of 30% to 50%, following a training and implementation schedule requiring as little as …

Changing the Way Laboratories Do Business Read More »

To access this post, you must purchase The Dark Report.

How “Lean” is Benefiting Early-Adopter Laboratories

CEO SUMMARY: First steps toward a radical change in clinical laboratory operations are under way in a handful of early-adopter laboratories. This movement is so new that little information about their successes can be published. But the early evidence is compelling. For those labs willing to take the plunge, implementation of quality management systems such …

How “Lean” is Benefiting Early-Adopter Laboratories Read More »

To access this post, you must purchase The Dark Report.

NY Labs Had Unique Problems During August Power Outage

WHEN THE POWER OUTAGE on August 14 hit states from New York to Michigan, the crisis plans of laboratories throughout the region were put to the test. For the most part, laboratories across this region were prepared and continued to deliver the most critical testing services. Even where operations were disrupted, once power was restored, …

NY Labs Had Unique Problems During August Power Outage Read More »

To access this post, you must purchase The Dark Report.

IMPATH Delisted by Nasdaq, Under Investigation by SEC

EFFECTIVE AUGUST 27, Nasdaq Stock Market, Inc. delisted the stock of IMPATH, Inc. Less than a week earlier, IMPATH had disclosed that it was under investigation by the Securities and Exchange Commission (SEC). IMPATH can truly be described as a company under siege. It is short of cash, under regulatory investigation, and defending itself from …

IMPATH Delisted by Nasdaq, Under Investigation by SEC Read More »

To access this post, you must purchase The Dark Report.

20% Medicare Co-Pay A Blow to Regional Labs

CEO SUMMARY: Informed speculation indicates that private health insurers are likely to adopt some form of laboratory test co-payment if the proposed Medicare 20% lab test co-pay legislation becomes law. For hospital laboratory outreach programs, the resulting reduction of reimbursement and associated higher costs of billing small amounts to patients would prove to be financially …

20% Medicare Co-Pay A Blow to Regional Labs Read More »

To access this post, you must purchase The Dark Report.

“September 8, 2003 Intelligence: Late Breaking Lab News”

Early last week, Laboratory Corporation of America announced an out-of-court settlement in its lawsuit involving its subsidiary, DIANON Systems, Inc. As plaintiff, DIANON had sued five former DIANON employees and their new company, DiaPath LLC. The claims involved “unfair trade practices” by DiaPath representatives, who had approached DIANON customers and encouraged them to switch their …

“September 8, 2003 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

;